Hourly refreshWed, Sep 2, 2026

Press Release Database

Recent press releases, indexed by topic.
Topic

Finance

24,967 press releases indexed under finance.

AllFinanceCryptoAISaaSHealthcareReal EstateEnergyRetailAutomotiveGamingMediaEducation
DownloadExcelTXT
Finance

Lorenzo Grandi, STMicroelectronics’ President and CFO to speak at Citi investor conference

Lorenzo Grandi, STMicroelectronics’ President and CFO to speak at Citi investor conference

Sep 2 · 06:00GlobeNewswire
Finance

Civinity and Sail Invest acquire Admeo, which manages 160 buildings, for EUR 4.3 million

Civinity, a building maintenance, engineering and technology solutions group, together with Sail Invest, a company controlled by Domas Dargis, has completed the acquisition of the Vilnius-based building management company Admeo. Through their jointly controlled company SPV 31, the buyers acquired 100% of the shares in Admeo.

Sep 2 · 05:58GlobeNewswire
Finance

Jyske Bank enters into an agreement to acquire Formuepleje

Jyske Bank A/S (Jyske Bank) has entered into a binding agreement with the shareholders of FP Kapital A/S on the acquisition of 100% of the shares of FP Kapital A/S (Formuepleje).

Sep 2 · 05:58GlobeNewswire
Finance

CFSI obtiene el Estándar Avanzado de Ciberseguridad del Departamento de Guerra de EE.UU.

- Cellebrite Federal Solutions, Inc. (CFSI) obtiene el Estándar Avanzado de Ciberseguridad del Departamento de Guerra de EE.UU., reforzando el compromiso con la seguridad de las operaciones federales TYSONS CORNER, Va., 2 de septiembre de 2026 /PRNewswire/ -- Cellebrite (Nasdaq: CLBT), un...

Sep 2 · 05:22PR Newswire
Finance · Healthcare

Innate Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

MARSEILLE, France, September 02, 2026--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate in a fireside chat and one-on-one investor meetings at the following conference:

Sep 2 · 05:00mlpr-businesswire
Finance

Cellebrite Federal Solutions, Inc. (CFSI) erfüllt den fortschrittlichen Cybersicherheitsstandard des US-Kriegsministeriums und unterstreicht damit sein Bekenntnis zu sicheren Abläufen bei Bundesbehörden

TYSONS CORNER, Virginia, 2. September 2026 /PRNewswire/ -- Cellebrite (Nasdaq: CLBT), ein weltweit führender Anbieter von KI-gestützten digitalen Ermittlungs- und Aufklärungslösungen für den öffentlichen und privaten Sektor, gab heute bekannt, dass seine Tochtergesellschaft Cellebrite...

Sep 2 · 04:49PR Newswire
Finance

Class Action Lawsuit Filed Against Aardvark Therapeutics, Inc. (AARD) ...

(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 2, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Aardvark Therapeutics, Inc. (NASDAQ:AARD) securities. If you suffered a loss on your Aardvark Therapeutics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Aardvark Therapeutics, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: This lawsuit is on behalf of a class ..

Sep 2 · 04:30PR-Inside
Finance

Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Contact Levi & Korsinsky ...

(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 2, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) securities. If you suffered a loss on your ARS Pharmaceuticals investment and would like to explore a potential recovery under the federal securities laws, Learn about ARS Pharmaceuticals Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ARS Pharmaceuticals, ..

Sep 2 · 04:30PR-Inside
Finance

Lost Money on Aardvark Therapeutics, Inc. (AARD)? Contact Levi & Korsinsky ...

(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 2, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Aardvark Therapeutics, Inc. (NASDAQ:AARD) securities. If you suffered a loss on your Aardvark Therapeutics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Aardvark Therapeutics, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: This lawsuit is on behalf of a class ..

Sep 2 · 04:10PR-Inside
Finance

Contact Levi & Korsinsky by September 29, 2026 to Join Class Action ...

(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 2, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Wise Group plc (NASDAQ:WSE) securities. If you suffered a loss on your Wise Group plc investment and would like to explore a potential recovery under the federal securities laws, Learn about Wise Group plc Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..

Sep 2 · 04:05PR-Inside
Finance

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit

NEW YORK, Sept. 1, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) between March 9, 2026 and June 24, 2026, inclusive (the "Class Period"), of the important October 5, 2026 lead...

Sep 2 · 03:58PR Newswire
Finance

AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, Sept. 1, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Aardvark Therapeutics, Inc. (NASDAQ: AARD): (i) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement")...

Sep 2 · 03:47PR Newswire
← Prev1232081Next →